Literature DB >> 21981780

Absence of an orphan mitochondrial protein, c19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation.

Monika B Hartig1, Arcangela Iuso, Tobias Haack, Tomasz Kmiec, Elzbieta Jurkiewicz, Katharina Heim, Sigrun Roeber, Victoria Tarabin, Sabrina Dusi, Malgorzata Krajewska-Walasek, Sergiusz Jozwiak, Maja Hempel, Juliane Winkelmann, Matthias Elstner, Konrad Oexle, Thomas Klopstock, Wolfgang Mueller-Felber, Thomas Gasser, Claudia Trenkwalder, Valeria Tiranti, Hans Kretzschmar, Gerd Schmitz, Tim M Strom, Thomas Meitinger, Holger Prokisch.   

Abstract

The disease classification neurodegeneration with brain iron accumulation (NBIA) comprises a clinically and genetically heterogeneous group of progressive neurodegenerative disorders characterized by brain iron deposits in the basal ganglia. For about half of the cases, the molecular basis is currently unknown. We used homozygosity mapping followed by candidate gene sequencing to identify a homozygous 11 bp deletion in the orphan gene C19orf12. Mutation screening of 23 ideopathic NBIA index cases revealed two mutated alleles in 18 of them, and one loss-of-function mutation is the most prevalent. We also identified compound heterozygous missense mutations in a case initially diagnosed with Parkinson disease at age 49. Psychiatric signs, optic atrophy, and motor axonal neuropathy were common findings. Compared to the most prevalent NBIA subtype, pantothenate kinase associated neurodegeneration (PKAN), individuals with two C19orf12 mutations were older at age of onset and the disease progressed more slowly. A polyclonal antibody against the predicted membrane spanning protein showed a mitochondrial localization. A histopathological examination in a single autopsy case detected Lewy bodies, tangles, spheroids, and tau pathology. The mitochondrial localization together with the immunohistopathological findings suggests a pathomechanistic overlap with common forms of neurodegenerative disorders.
Copyright © 2011 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21981780      PMCID: PMC3188837          DOI: 10.1016/j.ajhg.2011.09.007

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  14 in total

1.  Merlin--rapid analysis of dense genetic maps using sparse gene flow trees.

Authors:  Gonçalo R Abecasis; Stacey S Cherny; William O Cookson; Lon R Cardon
Journal:  Nat Genet       Date:  2001-12-03       Impact factor: 38.330

Review 2.  Genetics of neurodegeneration with brain iron accumulation.

Authors:  Allison Gregory; Susan J Hayflick
Journal:  Curr Neurol Neurosci Rep       Date:  2011-06       Impact factor: 5.081

3.  Genotypic and phenotypic spectrum of PANK2 mutations in patients with neurodegeneration with brain iron accumulation.

Authors:  Monika B Hartig; Konstanze Hörtnagel; Barbara Garavaglia; Giovanna Zorzi; Tomasz Kmiec; Thomas Klopstock; Kevin Rostasy; Marina Svetel; Vladimir S Kostic; Markus Schuelke; Evelyn Botz; Adolf Weindl; Ivana Novakovic; Nardo Nardocci; Holger Prokisch; Thomas Meitinger
Journal:  Ann Neurol       Date:  2006-02       Impact factor: 10.422

4.  A genome-wide association study identifies three loci associated with mean platelet volume.

Authors:  Christa Meisinger; Holger Prokisch; Christian Gieger; Nicole Soranzo; Divya Mehta; Dieter Rosskopf; Peter Lichtner; Norman Klopp; Jonathan Stephens; Nicholas A Watkins; Panos Deloukas; Andreas Greinacher; Wolfgang Koenig; Matthias Nauck; Christian Rimmbach; Henry Völzke; Annette Peters; Thomas Illig; Willem H Ouwehand; Thomas Meitinger; H-Erich Wichmann; Angela Döring
Journal:  Am J Hum Genet       Date:  2008-12-24       Impact factor: 11.025

5.  A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome.

Authors:  B Zhou; S K Westaway; B Levinson; M A Johnson; J Gitschier; S J Hayflick
Journal:  Nat Genet       Date:  2001-08       Impact factor: 38.330

6.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

7.  Human non-synonymous SNPs: server and survey.

Authors:  Vasily Ramensky; Peer Bork; Shamil Sunyaev
Journal:  Nucleic Acids Res       Date:  2002-09-01       Impact factor: 16.971

8.  An isoform of hPANK2, deficient in pantothenate kinase-associated neurodegeneration, localizes to mitochondria.

Authors:  Konstanze Hörtnagel; Holger Prokisch; Thomas Meitinger
Journal:  Hum Mol Genet       Date:  2003-02-01       Impact factor: 6.150

9.  Mutations in the fatty acid 2-hydroxylase gene are associated with leukodystrophy with spastic paraparesis and dystonia.

Authors:  Simon Edvardson; Hiroko Hama; Avraham Shaag; John Moshe Gomori; Itai Berger; Dov Soffer; Stanley H Korman; Ilana Taustein; Ann Saada; Orly Elpeleg
Journal:  Am J Hum Genet       Date:  2008-11       Impact factor: 11.025

10.  NCBI Reference Sequences: current status, policy and new initiatives.

Authors:  Kim D Pruitt; Tatiana Tatusova; William Klimke; Donna R Maglott
Journal:  Nucleic Acids Res       Date:  2008-10-16       Impact factor: 16.971

View more
  75 in total

1.  Novel case of neurodegeneration with brain iron accumulation 4 (NBIA4) caused by a pathogenic variant affecting splicing.

Authors:  Peter Sparber; Andrey Marakhonov; Alexandra Filatova; Inna Sharkova; Mikhail Skoblov
Journal:  Neurogenetics       Date:  2018-11-03       Impact factor: 2.660

2.  The Ets transcription factor EHF as a regulator of cornea epithelial cell identity.

Authors:  Denise N Stephens; Rachel Herndon Klein; Michael L Salmans; William Gordon; Hsiang Ho; Bogi Andersen
Journal:  J Biol Chem       Date:  2013-10-18       Impact factor: 5.157

3.  A Novel Deletion Mutation of Exon 2 of the C19orf12 Gene in an Omani Family with Mitochondrial Membrane Protein-Associated Neurodegeneration (MPAN).

Authors:  Nabil Al Macki; Ismail Al Rashdi
Journal:  Oman Med J       Date:  2017-01

Review 4.  The neuropathology of neurodegeneration with brain iron accumulation.

Authors:  Michael C Kruer
Journal:  Int Rev Neurobiol       Date:  2013       Impact factor: 3.230

Review 5.  Movement disorders in mitochondrial disease.

Authors:  Roula Ghaoui; Carolyn M Sue
Journal:  J Neurol       Date:  2018-01-06       Impact factor: 4.849

6.  Levodopa-induced dyskinesias in mitochondrial membrane protein-associated neurodegeneration.

Authors:  Daniel Savitt; Joseph Jankovic
Journal:  Neurol Clin Pract       Date:  2019-02

7.  13-year diagnostic delay as cerebral palsy of an Iraqi patient with NBIA type 4.

Authors:  Ameer Shaker Hadi; Nebal Waill Saadi; Qusay Abed Fahad
Journal:  Neurol Clin Pract       Date:  2019-06

8.  Freezing of Backward Gait.

Authors:  Raul Martinez-Fernandez; Nuria Caballol; Laura Castrillo; Paul Krack
Journal:  Mov Disord Clin Pract       Date:  2014-06-06

9.  New NBIA subtype: genetic, clinical, pathologic, and radiographic features of MPAN.

Authors:  Penelope Hogarth; Allison Gregory; Michael C Kruer; Lynn Sanford; Wendy Wagoner; Marvin R Natowicz; Robert T Egel; S H Subramony; Jennifer G Goldman; Elizabeth Berry-Kravis; Nicola C Foulds; Simon R Hammans; Isabelle Desguerre; Diana Rodriguez; Callum Wilson; Andrea Diedrich; Sarah Green; Huong Tran; Lindsay Reese; Randall L Woltjer; Susan J Hayflick
Journal:  Neurology       Date:  2012-12-26       Impact factor: 9.910

Review 10.  Ophthalmic manifestations of inherited neurodegenerative disorders.

Authors:  Hannah M Kersten; Richard H Roxburgh; Helen V Danesh-Meyer
Journal:  Nat Rev Neurol       Date:  2014-05-20       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.